Elena Elstner

3.5k total citations · 1 hit paper
58 papers, 3.0k citations indexed

About

Elena Elstner is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Elena Elstner has authored 58 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 21 papers in Hematology and 13 papers in Oncology. Recurrent topics in Elena Elstner's work include Retinoids in leukemia and cellular processes (24 papers), Peroxisome Proliferator-Activated Receptors (17 papers) and Acute Myeloid Leukemia Research (15 papers). Elena Elstner is often cited by papers focused on Retinoids in leukemia and cellular processes (24 papers), Peroxisome Proliferator-Activated Receptors (17 papers) and Acute Myeloid Leukemia Research (15 papers). Elena Elstner collaborates with scholars based in United States, Germany and Denmark. Elena Elstner's co-authors include H. Phillip Koeffler, David Heber, Jonathan Said, Elizabeth A. Williamson, Hiroya Asou, Martin Fenner, Milan R. Uskoković, Peter Shintaku, Kozo Koshizuka and Carsten Müller‐Tidow and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Elena Elstner

57 papers receiving 2.9k citations

Hit Papers

Ligands for peroxisome proliferator-activated receptorγ a... 1998 2026 2007 2016 1998 200 400 600

Peers

Elena Elstner
Stephen Hiscox United Kingdom
Allard Kaptein Netherlands
D M Peehl United States
John J. Grygiel Australia
Toshiyuki Sakamaki United States
Elena Elstner
Citations per year, relative to Elena Elstner Elena Elstner (= 1×) peers Lucia Magnelli

Countries citing papers authored by Elena Elstner

Since Specialization
Citations

This map shows the geographic impact of Elena Elstner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Elstner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Elstner more than expected).

Fields of papers citing papers by Elena Elstner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Elstner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Elstner. The network helps show where Elena Elstner may publish in the future.

Co-authorship network of co-authors of Elena Elstner

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Elstner. A scholar is included among the top collaborators of Elena Elstner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Elstner. Elena Elstner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khoo, Boon Yin, et al.. (2016). Pretreatment of BMSCs with TZD solution decreases the proliferation rate of MCF-7 cells by reducing FGF4 protein expression. Molecular Medicine Reports. 13(4). 3406–3414. 1 indexed citations
2.
Afanasyev, Boris V., Elena Elstner, Axel R. Zander, & Russian Federation. (2009). A. J. Friedenstein, founder of the mesenchymal stem cell concept. 1(3). 30 indexed citations
3.
Liu, Hongyu, Chuanbing Zang, Anna Emde, et al.. (2008). Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. European Journal of Pharmacology. 591(1-3). 43–51. 107 indexed citations
4.
Eucker, Jan, Ivana Zavrski, Holger Krebbel, et al.. (2004). Ligands of peroxisome proliferator-activated receptor γ induce apoptosis in multiple myeloma. Anti-Cancer Drugs. 15(10). 955–960. 34 indexed citations
5.
Zang, C., et al.. (2003). PPARγ Ligands and ATRA Inhibit the Invasion of Human Breast Cancer Cells in vitro. Breast Cancer Research and Treatment. 79(1). 63–74. 142 indexed citations
6.
Elstner, Elena, Elizabeth A. Williamson, C. Zang, et al.. (2002). Novel Therapeutic Approach: Ligands for PPARγ and Retinoid Receptors Induce Apoptosis in bcl-2-positive Human Breast Cancer Cells. Breast Cancer Research and Treatment. 74(2). 155–165. 74 indexed citations
7.
Linker‐Israeli, Mariana, Elena Elstner, James R. Klinenberg, Daniel J. Wallace, & H. Phillip Koeffler. (2001). Vitamin D3 and Its Synthetic Analogs Inhibit the Spontaneous in Vitro Immunoglobulin Production by SLE-Derived PBMC. Clinical Immunology. 99(1). 82–93. 107 indexed citations
9.
Goldstein, SA, Kozo Koshizuka, Elena Elstner, et al.. (2000). Effects of long-term administration of vitamin D3 analogs to mice. Journal of Endocrinology. 165(1). 163–172. 32 indexed citations
10.
Elstner, Elena, Moray J. Campbell, Reinhold Munker, et al.. (1999). Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells. The Prostate. 40(3). 141–149. 42 indexed citations
11.
Munker, Reinhold, et al.. (1998). Vitamin D Analogs, Leukemia and WAF1. Leukemia & lymphoma. 31(3-4). 279–284. 8 indexed citations
12.
Grillier‐Vuissoz, Isabelle, T Umiel, Elena Elstner, SJ Collins, & HP Koeffler. (1997). Alterations of differentiation, clonal proliferation, cell cycle progression and bcl-2 expression in RARα-altered sublines of HL-60. Leukemia. 11(3). 393–400. 17 indexed citations
13.
Vos, Sven de, Stuart Holden, David Heber, et al.. (1997). Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines. The Prostate. 31(2). 77–83. 35 indexed citations
15.
Pakkala, Seppo, Sven de Vos, Elena Elstner, et al.. (1995). Vitamin D3 analogs: Effect on leukemic clonal growth and differentiation, and on serum calcium levels. Leukemia Research. 19(1). 65–72. 59 indexed citations
16.
Lee, Young Yiul, Seppo Pakkala, Sven de Vos, et al.. (1994). 1,25(OH)2-16ENE-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia. Leukemia Research. 18(6). 453–463. 48 indexed citations
17.
Maciejewski, Jaroslaw P., et al.. (1991). Comparative analysis of the influences of IL-1, IL-3 and GM-CSF on the commitment of granulocyte-macrophage progenitors in vitro. Annals of Hematology. 63(5). 242–248. 3 indexed citations
18.
Elstner, Elena, et al.. (1989). Bone Marrow Stromal Cells in Myelodysplastic Syndromes and Acute Nonlymphocytic Leukemia. Hämatologie und Bluttransfusion. 32. 168–171. 1 indexed citations
20.
Elstner, Elena, et al.. (1987). Sensitivity of Stromal Elements from Human Bone Marrow Cells to Cytosine Arabinoside In Vitro. Hämatologie und Bluttransfusion. 31. 177–180. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026